CALR and acute lymphoblastic leukemia: To study ICD drug-mediated stimulation of surface CRT presentation in T-ALL cells, we used CRISPR-Cas9-mediated genome editing25 to silence CRT expression (CRT null (CRT−/−)) in Jurkat T-lymphoblasts.